admin@adna.org.au 03 8840 5072
IL17 and IL23 have largely superseded TNF inhibitors in psoriasis. However, they still play a significant role in rheumatology and gastroenterology.
Join Dr Andrew Östör (rheumatologist), Dr Emily Wright (gastroenterologist) and A/Prof Chris Baker(dermatologist) as they discuss where TNF inhibitors fit in the treatment options for psoriasis and explore TNF inhibitors and their competitors in inflammatory arthritis and inflammatory bowel disease (IBD).
Join The Skin Hospital for a one-day conference designed for medical students, JMOs, nurses or any health professional with a special interest in skin. From birthmarks to infantile rashes & practical workshops to skin cancer panel discussions, this year's Skin...
One of the key actions of the National Women’s Health Strategy 2020-2030 is to help women and their health care providers manage the effects of menopause by increasing menopause training among health professionals. The Senate Inquiry into issues related to menopause...
The Australasian Dermatology Registry (www.australasiandermatologyregistry.org.au) is hosting an online information evening “The First Year of the Australasian Dermatology Registry” for dermatologists and nurses on Tuesday 13th May 2025 at 7.30pm (AEDT). Join us for...
Melanoma Institute Australia invites you to register for an educational webinar for Nurses, Dermatologists, Skin Cancer Doctors, GPs, Pharmacists and other healthcare professionals with an interest in skin cancer. Hosted by A/Prof Paul Fishburn (Skin Cancer GP) and...
